GUD:TSX, Knight Therapeutics Inc.

GUD stock overview

Knight Therapeutics Inc. (GUD:TSX) closed at $12.06 on November 13, 2026, up 0.08% on the day. The stock trades 1.0% below its 52-week high of $12.19 and 113.1% above its 52-week low of $5.66. Over the past year, it gained 96.4%. Knight Therapeutics Inc. is part of the Life Sciences sector (Biotechnology).

Key figures

Price: $12.06
Day change: +0.08%
Volume: 45,523
Average volume: 76,088
Market cap: 1B+
52-week range: $5.66 – $12.19
50-day average: $10.76
200-day average: $8.78

Price action over the past year

In 252 trading sessions since November 13, 2025, GUD closed higher on 140 days (56%). Its best day was May 7, 2026 (+11.19%) and its worst was August 4, 2026 (-5.08%). The stock moved 10% or more in a single session 1 time. It opened at least 5% above the previous day's high 1 time.

Recent signals

Nov 13, 2026: Hit a new 52-Week High of $12.06 (New Highs/Lows scanner)
Nov 13, 2026: Trading sideways between $10.80 and $12.06 over 30 days (Sideways scanner)
Nov 5, 2026: News catalyst: Earnings (News Catalysts scanner)

GUD news

Nov 13, 2026: Knight Therapeutics Inc. named one of Quebec's Top Growing Companies in The Globe and Mail's inaugural ranking, with 53% three-year revenue growth
Nov 9, 2026: What Knight Therapeutics (GUD) Said on Its Q3 Earnings Call
Nov 5, 2026: Knight Therapeutics Inc (KHTRF) (Q3 2026) Earnings Call Highlights: Record Revenue, Raised ...
Nov 5, 2026: Knight Therapeutics Reports Third Quarter 2026 Results
Oct 29, 2026: Notice of Knight Therapeutics' Third Quarter 2026 Results Conference Call
Oct 6, 2026: Knight Therapeutics Announces Regulatory Approval of NIKTIMVO® in Brazil
Oct 6, 2026: Knight Therapeutics Announces Launch of TAVALISSE® in Brazil
Sep 30, 2026: Kyowa Kirin, Knight agree Latin American distribution deal for mogamulizumab

About Knight Therapeutics Inc.

Knight Therapeutics Inc operates in the healthcare sector. It is a specialty and generic drug manufacturing company. It deals mainly in pharmaceutical products, consumer health products and medical devices.

Similar stocks

Find more stocks like GUD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.